Stem cell features of benign and malignant prostate epithelial cells

Journal of Urology

Volumn 160, Issue 6 II, 1998, Pages 2381-2392

  De Marzo, Angelo M ^a   Nelson, William G ^a   Meeker, Alan K ^a   Coffey, Donald S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cyclins; Prostatic hypertrophy; Prostatic neoplasms; Stem cells; Transferases

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; DNA; HYDROPEROXIDE;

ANIMAL CELL; ARTICLE; BASAL CELL; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN EXPRESSION; RAT; SECRETORY CELL; STEM CELL;

EID: 0032870826     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)62196-7     Document Type: Article

References (148)

1. Isaacs, J. T. and Coffey, D. S.: Etiology and disease process of benign prostatic hyperplasia. Prostate, suppl., 2: 33, 1989.
2. McNeal, J. E.: Anatomy of the prostate and morphogenesis of BPH. Prog. Clin. Biol. Res., 145: 27, 1984.
3. Berry, S. J., Coffey, D. S., Walsh, P. C. and Ewing, L. L.: The development of human benign prostatic hyperplasia with age. J. Urol., 132: 474, 1984.
4. Coffey, D. S. and Walsh, P. C.: Clinical and experimental studies of benign prostatic hyperplasia. Urol. Clin. N. Amer., 17: 461, 1990.
5. Garraway, W. M. and Alexander, F. E.: Prostate disease: epidemiology, natural history and demographic shifts. Brit. J. Urol., 79: 3, 1997.
6. Maini, A., Archer, C., Wang, C. Y. and Haas, G. P.: Comparative pathology of benign prostatic hyperplasia and prostate cancer. In Vivo, 11: 293, 1997.
7. Lawson, R. K.: Role of growth factors in benign prostatic hyperplasia. Eur. Urol., 32: 22, 1997.
8. Lee, C., Kozlowski, J. M. and Grayhack, J. T.: Intrinsic and extrinsic factors controlling benign prostatic growth. Prostate, 31: 131, 1997.
9. Lee, C.: Cellular interactions in prostate cancer. Brit. J. Urol., 79: 21, 1997.
10. Foster, C. S. and Ke, Y.: Stem cells in prostatic epithelia. Int. J. Exp. Path., 78: 311, 1997.
11. Lord, B.: Biology of the haemopoietic stem cell. In: Stem Cells. Edited by C. S. Potten. London: Academic Press, p. 401, 1997.
12. Reid, L. M.: Stem cell-fed maturational lineages and gradients in signals - relevance to differentiation of epithelia. Molec. Biol. Rep., 23: 21, 1996.
13. Potten, C. S.: Stem Cells. London: Academic Press, 1997.
14. Miller, S. J., Lavker, R. M. and Sun, T.-T.: Keratinocyte stem cells of cornea, skin and hair follicles. In: Stem Cells. Edited by C. S. Potten. London: Academic Press, p. 331, 1997.
15. Trott, K. R.: Tumour stem cells: the biological concept and its application in cancer treatment. Radiother. Oncol., 30: 1, 1994.
16. Watt, F. M. and Jones, P. H.: Expression and function of the keratinocyte integrins. Dev. Suppl., p. 185, 1993.
17. Gandarillas, A. and Watt, F. M.: c-Myc promotes differentiation of human epidermal stem cells. Genes Dev., 11: 2869, 1997.
18. Jones, P. H., Harper, S. and Watt, F. M.: Stem cell patterning and fate in human epidermis. Cell, 80: 83, 1995.
19. Wei, Z. G., Sun, T. T. and Lavker, R. M.: Rabbit conjunctival and corneal epithelial cells belong to two separate lineages. Invest. Ophthalmol. Vis. Sci., 37: 523, 1996.
20. Wei, Z. G., Lin, T., Sun, T. T. and Lavker, R. M.: Clonal analysis of the in vivo differentiation potential of keratinocytes. Invest. Ophthalmol. Vis. Sci., 38: 753, 1997.
21. van den Bos, C., Mosca, J. D., Winkles, J., Kerrigan, L., Burgess, W. H. and Marshak, D. R.: Human mesenchymal stem cells respond to fibroblast growth factors. Hum. Cell, 10: 45, 1997.
22. Pierce, G. B.: Teratocarcinoma: model for a developmental concept of cancer. Curr. Topics Dev. Biol., 2: 223, 1967.
23. Pierce, G. B. and Speers, W. C.: Tumors as caricatures of the process of tissue renewal: prospects for therapy by directing differentiation. Cancer Res., 48: 1996, 1988.
24. Sell, S. and Pierce, G. B.: Maturation arrest of stem cell differentiation is a common pathway for the cellular origin of teratocarcinomas and epithelial cancers. Lab. Invest., 70: 6, 1994.
25. Buick, R. N. and Pollak, M. N.: Perspectives on clonogenic tumor cells, stem cells, and oncogenes. Cancer Res., 44: 4909, 1984.
26. Kummermehr, J. and Trott, K.-R.: Tumour stem cells. In: Stem Cells. Edited by C. S. Potten. London: Academic Press, p. 363, 1997.
27. Potten, C. S. and Morris, R. J.: Epithelial stem cells in vivo. J. Cell Sci., suppl., 10: 45, 1988.
28. Potten, C. S. and Loeffler, M.: Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. Development, 110: 1001, 1990.
29. Bonkhoff, H., Stein, U. and Remberger, K.: Multidirectional differentiation in the normal, hyperplastic, and neoplastic human prostate: simultaneous demonstration of cell-specific epithelial markers. Hum. Path., 25: 42, 1994.
30. Bonkhoff, H. and Remberger, K.: Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model. Prostate, 28: 98, 1996.
31. De Marzo, A., Meeker, A., Epstein, J. and Coffey, D.: Prostate stem cell compartments: expression of p27Kip1 in normal, hyperplastic and cancer cells. Amer. J. Path., 153: 911, 1998.
32. Kyprianou, N. and Isaacs, J. T.: Activation of programmed cell death in the rat ventral prostate after castration. Endocrinology, 122: 552, 1988.
33. DeKlerk, D. P. and Coffey, D. S.: Quantitative determination of prostatic epithelial and stromal hyperplasia by a new technique. Biomorphometrics. Invest. Urol., 16: 240, 1978.
34. Sufrin, G., Heston, W. D., Hazra, T. and Coffey, D. S.: The effect of radiation on prostatic growth. Invest. Urol., 13: 418, 1976.
35. Kinbara, H., Cunha, G. R., Boutin, E., Hayashi, N. and Kawamura, J.: Evidence of stem cells in the adult prostatic epithelium based upon responsiveness to mesenchymal inductors. Prostate, 29: 107, 1996.
36. Cunha, G. R., Lung, B. and Reese, B.: Glandular epithelial induction by embryonic mesenchyme in adult bladder epithelium of BALB/c mice. Invest. Urol., 17: 302, 1980.
37. McNeal, J. E.: Regional morphology and pathology of the prostate. Amer. J. Clin. Path., 49: 347, 1968.
38. McNeal, J. E.: The zonal anatomy of the prostate. Prostate, 2: 35, 1981.
39. McNeal, J. E.: Normal histology of the prostate. Amer. J. Surg. Path., 12: 619, 1988.
40. Sherwood, E. R., Berg, L. A., Mitchell, N. J., McNeal, J. E., Kozlowski, J. M. and Lee, C.: Differential cytokeratin expression in normal, hyperplastic and malignant epithelial cells from human prostate. J. Urol., 143: 167, 1990.
41. Leav, I., McNeal, J. E., Kwan, P. W., Komminoth, P. and Merk, F. B.: Androgen receptor expression in prostatic dysplasia (prostatic intraepithelial neoplasia) in the human prostate: an immunohistochemical and in situ hybridization study. Prostate, 29: 137, 1996.
42. Bonkhoff, H. and Remberger, K.: Widespread distribution of nuclear androgen receptors in the basal cell layer of the normal and hyperplastic human prostate. Virchows Arch. A Path. Anat. Histopath., 422: 35, 1993.
43. Walensky, L. D., Coffey, D. S., Chen, T. H., Wu, T. C. and Pasternack, G. R.: A novel M(r) 32,000 nuclear phosphoprotein is selectively expressed in cells competent for self-renewal. Cancer Res., 53: 4720, 1993.
44. Kadkol, S. S., Brody, J. R., Epstein, J. I., Kuhajda, F. P. and Pasternack, G. R.: The novel nuclear phosphoprotein pp32 is highly expressed in intermediate and high grade prostate cancer. Prostate, 34: 231, 1998.
45. Lee, W. H., Morton, R. A., Epstein, J. I., Brooks, J. D., Campbell, P. A., Bova, G. S., Hsieh, W. S., Isaacs, W. B. and Nelson, W. G.: Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc. Natl. Acad. Sci. USA, 91: 11733, 1994.
46. McDonnell, T. J., Troncoso, P., Brisbay, S. M., Logothetis, C., Chung, L. W., Hsieh, J. T., Tu, S. M. and Campbell, M. L.: Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res., 52: 6940, 1992.
47. Verhagen, A. P., Aalders, T. W., Ramaekers, F. C., Debruyne, F. M. and Schalken, J. A.: Differential expression of keratins in the basal and luminal compartments of rat prostatic epithelium during degeneration and regeneration. Prostate, 13: 25, 1988.
48. Verhagen, A. P., Ramaekers, F. C., Aalders, T. W., Schaafsma, H. E., Debruyne, F. M. and Schalken, J. A.: Colocalization of basal and luminal cell-type cytokeratins in human prostate cancer. Cancer Res., 52: 6182, 1992.
49. Xue, Y., Smedts, F., Umbas, R., Aalders, T. W., Debruyne, F. M., de la Rosette, J. J. and Schalken, J. A.: Changes in keratin expression during the development of benign prostatic hyperplasia. Eur. Urol., 32: 332, 1997.
50. Sar, M., Lubahn, D. B., French, F. S. and Wilson, E. M.: Immunohistochemical localization of the androgen receptor in rat and human tissues. Endocrinology, 127: 3180, 1990.
51. Epstein, J. I.: PSA and PAP as immunohistochemical markers in prostate cancer. Urol. Clin. N. Amer., 20: 757, 1993.
52. Heyns, W., Van Damme, B. and De Moor, P.: Secretion of prostatic binding protein by rat ventral prostate: influence of age and androgen. Endocrinology, 103: 1090, 1978.
53. Sensibar, J. A., Alger, B., Tseng, A., Berg, L. and Lee, C.: Proteins of the rat prostate. III. Effect of testosterone on protein synthesis by the ventral prostate of castrated rats. J. Urol., 143: 161, 1990.
54. Lee, W. H., Isaacs, W. B., Bova, G. S. and Nelson, W. G.: CG island methylation changes near the GSTP1 gene in prostatic carcinoma cells detected using the polymerase chain reaction: a new prostate cancer biomarker. Cancer Epidemiol. Biomarkers Prev., 6: 443, 1997.
55. Cookson, M. S., Reuter, V. E., Linkov, I. and Fair, W. R.: Glutathione S-transferase PI (GST-pi) class expression by immunohistochemistry in benign and malignant prostate tissue. J. Urol., 157: 673, 1997.
56. Moskaluk, C. A., Duray, P. H., Cowan, K. H., Linehan, M. and Merino, M. J.: Immunohistochemical expression of pi-class glutathione S-transferase is down-regulated in adenocarcinoma of the prostate. Cancer, 79: 1595, 1997.
57. Bonkhoff, H., Stein, U. and Remberger, K.: The proliferative function of basal cells in the normal and hyperplastic human prostate. Prostate, 24: 114, 1994.
58. McNeal, J. E., Haillot, O. and Yemoto, C.: Cell proliferation in dysplasia of the prostate: analysis by PCNA immunostaining. Prostate, 27: 258, 1995.
59. Mao, P. and Angrist, A.: The fine structure of the basal cell of human prostate. Lab. Invest., 15: 1768, 1966.
60. Lipschutz, J. H., Foster, B. A. and Cunha, G. R.: Differentiation of rat neonatal ventral prostates grown in a serum-free organ culture system. Prostate, 32: 35, 1997.
61. English, H. F., Santen, R. J. and Isaacs, J. T.: Response of glandular versus basal rat ventral prostatic epithelial cells to androgen withdrawal and replacement. Prostate, 11: 229, 1987.
62. Lee, C., Sensibar, J. A., Dudek, S. M., Hiipakka, R. A. and Liao, S. T.: Prostatic ductal system in rats: regional variation in morphological and functional activities. Biol. Reprod., 43: 1079, 1990.
63. Kim, I. Y., Ahn, H. J., Zelner, D. J., Park, L., Sensibar, J. A. and Lee, C.: Expression and localization of transforming growth factor-beta receptors type I and type II in the rat ventral prostate during regression. Mol. Endocrinol., 10: 107, 1996.
64. Blackburn, E. H.: The molecular structure of centromeres and telomeres. Ann. Rev. Biochem., 53: 163, 1984.
65. Greider, C. W. and Blackburn, E. H.: Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell, 43: 405, 1985.
66. Greider, C. W. and Blackburn, E. H.: A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature, 337: 331, 1989.
67. Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L., Coviello, G. M., Wright, W. E., Weinrich, S. L. and Shay, J. W.: Specific association of human telomerase activity with immortal cells and cancer. Science, 266: 2011, 1994.
68. Counter, C. M., Hirte, H. W., Bacchetti, S. and Harley, C. B.: Telomerase activity in human ovarian carcinoma. Proc. Natl. Acad. Sci. USA, 91: 2900, 1994.
69. Hastie, N. D., Dempster, M., Dunlop, M. G., Thompson, A. M., Green, D. K. and Allshire, R. C.: Telomere reduction in human colorectal carcinoma and with ageing. Nature, 346: 866, 1990.
70. Harley, C. B., Futcher, A. B. and Greider, C. W.: Telomeres shorten during ageing of human fibroblasts. Nature, 345: 458, 1990.
71. Counter, C. M., Avilion, A. A., LeFeuvre, C. E., Stewart, N. G., Greider, C. W., Harley, C. B. and Bacchetti, S.: Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J., 11: 1921, 1992.
72. Harley, C. B., Kim, N. W., Prowse, K. R., Weinrich, S. L., Hirsch, K. S., West, M. D., Bacchetti, S., Hirte, H. W., Counter, C. M. and Greider, C. W.: Telomerase, cell immortality, and cancer. Cold Spring Harb. Symp. Quant. Biol., 59: 307, 1994.
73. Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C. P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S. and Wright, W. E.: Extension of life-span by introduction of telomerase into normal human cells. Science, 279: 349, 1998.
74. Meeker, A. K., Sommerfeld, H. J. and Coffey, D. S.: Telomerase is activated in the prostate and seminal vesicles of the castrated rat. Endocrinology, 137: 5743, 1996.
75. Harle-Bachor, C. and Boukamp, P.: Telomerase activity in the regenerative basal layer of the epidermis inhuman skin and in immortal and carcinoma-derived skin keratinocytes. Proc. Natl. Acad. Sci. USA, 93: 6476, 1996.
76. Kyo, S., Takakura, M., Kohama, T. and Inoue, M.: Telomerase activity in human endometrium. Cancer Res., 57: 610, 1997.
77. Yashima, K., Piatyszek, M. A., Saboorian, H. M., Virmani, A. K., Brown, D., Shay, J. W. and Gazdar, A. F.: Telomerase activity and in situ telomerase RNA expression in malignant and non-malignant lymph nodes. J. Clin. Path., 50: 110, 1997.
78. Ramirez, R. D., Wright, W. E., Shay, J. W. and Taylor, R. S.: Telomerase activity concentrates in the mitotically active segments of human hair follicles. J. Invest. Dermatol., 108: 113, 1997.
79. Lee, H. W., Blasco, M. A., Gottlieb, G. J., Horner, J. W., II, Greider, C. W. and DePinho, R. A.: Essential role of mouse telomerase in highly proliferative organs. Nature, 392: 569, 1998.
80. Ohyashiki, K., Ohyashiki, J. H., Nishimaki, J., Toyama, K., Ebihara, Y., Kato, H., Wright, W. E. and Shay, J. W.: Cytological detection of telomerase activity using an in situ telomeric repeat amplification protocol assay. Cancer Res., 57: 2100, 1997.
81. Shay, J. W. and Wright, W. E.: Telomerase activity in human cancer. Curr. Opinion Oncol., 8: 66, 1996.
82. Shay, J. W. and Gazdar, A. F.: Telomerase in the early detection of cancer. J. Clin. Path., 50: 106, 1997.
83. Meeker, A. K. and Coffey, D. S.: Telomerase: a promising marker of biological immortality of germ, stem, and cancer cells. A review. Biochemistry (Moscow), 62: 1323, 1997.
84. Sommerfeld, H. J., Meeker, A. K., Piatyszek, M. A., Bova, G. S., Shay, J. W. and Coffey, D. S.: Telomerase activity: a prevalent marker of malignant human prostate tissue. Cancer Res., 56: 218, 1996.
85. Scates, D. K., Muir, G. H., Venitt, S. and Carmichael, P. L.: Detection of telomerase activity in human prostate: a diagnostic marker for prostatic cancer? Brit. J. Urol., 80: 263, 1997.
86. Lin, Y., Uemura, H., Fujinami, K., Hosaka, M., Harada, M. and Kubota, Y.: Telomerase activity in primary prostate cancer. J. Urol., 157: 1161, 1997.
87. Chen, T. H., Brody, J. R., Romantsev, R. E., Yu, J. G., Kayler, A. E., Voneiff, E., Kuhajda, F. P. and Pasternack, G. R.: Structure of Pp32, an acidic nuclear protein which inhibits oncogene-induced formation of transformed foci. Molec. Biol. Cell, 7: 2045, 1996.
88. Malek, S. N., Katumuluwa, A. I. and Pasternack, G. R.: Identification and preliminary characterization of two related proliferation-associated nuclear phosphoproteins. J. Biol. Chem., 265: 13400, 1990.
89. Wang, F. L., Wang, Y., Wong, W. K., Liu, Y., Addivinola, F. J., Liang, P., Chen, L. B., Kantoff, P. W. and Pardee, A. B.: Two differentially expressed genes in normal human prostate tissue and in carcinoma. Cancer Res., 56: 3634, 1996.
90. Sun, Y., Lin, J., Katz, A. E. and Fisher, P. B.: Human prostatic carcinoma oncogene PTI-1 is expressed in human tumor cell lines and prostate carcinoma patient blood samples. Cancer Res., 57: 18, 1997.
91. Chuaqui, R. F., Englert, C. R., Strup, S. E., Vocke, C. D., Zhuang, Z., Duray, P. H., Bostwick, D. G., Linehan, W. M., Liotta, L. A. and Emmert-Buck, M. R.: Identification of a novel transcript up-regulated in a clinically aggressive prostate carcinoma. Urology, 50: 302, 1997.
92. Chang, G. T., Blok, L. J., Steenbeek, M., Veldscholte, J., van Weerden, W. M., van Steenbrugge, G. J. and Brinkmann, A. O.: Differentially expressed genes in androgen-dependent and -independent prostate carcinomas. Cancer Res., 57: 4075, 1997.
93. Reiter, R. E., Gu, Z., Watabe, T., Thomas, G., Szigeti, K., Davis, E., Wahl, M., Nisitani, S., Yamashiro, J., Le Beau, M. M., Loda, M. and Witte, O. N.: Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer. Proc. Natl. Acad. Sci. USA, 95: 1735, 1998.
94. Dong, J. T., Isaacs, W. B. and Isaacs, J. T.: Molecular advances in prostate cancer. Curr. Opinion Oncol., 9: 101, 1997.
95. Bova, G. S. and Isaacs, W. B.: Review of allelic loss and gain in prostate cancer. World J. Urol., 14: 338, 1996.
96. Isaacs, W. B.: Molecular genetics of prostate cancer. Cancer Surv., 25: 357, 1995.
97. Pickett, C. B. and Lu, A. Y.: Glutathione S-transferases: gene structure, regulation, and biological function. Ann. Rev. Biochem., 58: 743, 1989.
98. Coles, B. and Ketterer, B.: The role of glutathione and glutathione transferases in chemical carcinogenesis. Crit. Rev. Biochem. Molec. Biol., 25: 47, 1990.
99. Rushmore, T. H. and Pickett, C. B.: Glutathione S-transferases, structure, regulation, and therapeutic implications. J. Biol. Chem., 268: 11475, 1993.
100. Canada, A. T., Roberson, K. M., Vessella, R. L., Trump, D. L., Robertson, C. N. and Fine, R. L.: Glutathione and glutathione S-transferase in benign and malignant prostate cell lines and prostate tissues. Biochem. Pharmacol., 51: 87, 1996.
101. Brooks, J. D., Weinstein, M., Lin, X., Sun, Y., Pin, S. S., Bova, G. S., Epstein, J. I., Isaacs, W. B. and Nelson, W. G.: CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia. Cancer Epidemiol. Biomarkers Prev., 7: 531, 1998.
102. Leake, R.: The cell cycle and regulation of cancer cell growth. Ann. N. Y. Acad. Sci., 784: 252, 1996.
103. MacLachlan, T. K., Sang, N. and Giordano, A.: Cyclins, cyclin-dependent kinases and cdk inhibitors: implications in cell cycle control and cancer. Crit. Rev. Eukaryot. Gene Expr., 5: 127, 1995.
104. Kamb, A.: Cell-cycle regulators and cancer. Trends Genet., 11: 136, 1995.
105. Hartwell, L. H. and Kastan, M. B.: Cell cycle control and cancer. Science, 266: 1821, 1994.
106. McNeal, J. E. and Bostwick, D. G.: Intraductal dysplasia: a premalignant lesion of the prostate. Hum. Path., 17: 64, 1986.
107. Bostwick, D. G. and Montironi, R.: Prostatic intraepithelial neoplasia and the origins of prostatic carcinoma. Path. Res. Pract., 191: 828, 1995.
108. Bostwick, D. G.: Prospective origins of prostate carcinoma. Prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia. Cancer, 78: 330, 1996.
109. Bostwick, D. G., Pacelli, A. and Lopez-Beltran, A.: Molecular biology of prostatic intraepithelial neoplasia. Prostate, 29: 117, 1996.
110. Polyak, K., Hamilton, S. R., Vogelstein, B. and Kinzler, K. W.: Early alteration of cell-cycle-regulated gene expression in colorectal neoplasia. Amer. J. Path., 149: 381, 1996.
111. Roberts, J. M., Koff, A., Polyak, K., Firpo, E., Collins, S., Ohtsubo, M. and Massague, J.: Cyclins, Cdks, and cyclin kinase inhibitors. Cold Spring Harb. Symp. Quant. Biol., 59: 31, 1994.
112. Polyak, K., Lee, M. H., Erdjument-Bromage, H., Koff, A., Roberts, J. M., Tempst, P. and Massague, J.: Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell, 78: 59, 1994.
113. Toyoshima, H. and Hunter, T.: p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell, 78: 67, 1994.
114. Coats, S., Flanagan, W. M., Nourse, J. and Roberts, J. M.: Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle. Science, 272: 877, 1996.
115. Steeg, P. S. and Abrams, J. S.: Cancer prognostics: past, present and p27. Nat. Med., 3: 152, 1997.
116. Sherr, C. J.: Cancer cell cycles. Science, 274: 1672, 1996.
117. Yasui, W., Kudo, Y., Semba, S., Yokozaki, H. and Tahara, E.: Reduced expression of cyclin-dependent kinase inhibitor P27(Kip1) is associated with advanced stage and invasiveness of gastric carcinomas. Jap. J. Cancer Res., 88: 625, 1997.
118. Mori, M., Mimori, K., Shiraishi, T., Tanaka, S., Ueo, H., Sugimachi, K. and Akiyoshi, T.: P27 expression and gastric carcinoma. Nat. Med., 3: 593, 1997.
119. Tan, P., Cady, B., Wanner, M., Worland, P., Cukor, B., Magi-Galluzzi, C., Lavin, P., Draetta, G., Pagano, M. and Loda, M.: The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas. Cancer Res., 57: 1259, 1997.
120. Catzavelos, C., Bhattacharya, N., Ung, Y. C., Wilson, J. A., Roncari, L., Sandhu, C., Shaw, P., Yeger, H., Morava-Protzner, I., Kapusta, L., Franssen, E., Pritchard, K. I. and Slingerland, J. M.: Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer. Nat. Med., 3: 227, 1997.
121. Loda, M., Cukor, B., Tam, S. W., Lavin, P., Fiorentino, M., Draetta, G. F., Jessup, J. M. and Pagano, M.: Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat. Med., 3: 231, 1997.
122. Vailancourt, L., Ttu, B., Fradet, Y., Dupont, A., Gomez, J., Cusan, L., Suburu, E. R., Diamond, P., Candas, B. and Labrie, F.: Effect of neoadjuvant endocrine therapy (combined androgen blockade) on normal prostate and prostatic carcinoma. A randomized study. Amer. J. Surg. Path., 20: 86, 1996.
123. Gleave, M. E., Goldenberg, S. L., Jones, E. C., Bruchovsky, N. and Sullivan, L. D.: Biochemical and pathological effects of 8 months of neoadjuvant androgen withdrawal therapy before radical prostatectomy in patients with clinically confined prostate cancer. J. Urol., 155: 213, 1996.
124. Guo, Y. P., Sklar, G. N., Borkowski, A. and Kyprianou, N.: Loss of the cyclin-dependent kinase inhibitor p27(Kip1) protein in human prostate cancer correlates with tumor grade. Clin. Cancer Res., 3: 2269, 1997.
125. Yang, R. M., Naitoh, J., Murphy, M., Wang, H. J., Phillipson, J., deKernion, J. B., Loda, M. and Reiter, R. E.: Low p27 expression predicts poor disease-free survival in patients with prostate cancer. J. Urol., 159: 941, 1998.
126. Tsihlias, J., Kapusta, L. R., DeBoer, G., Morava-Protzner, I., Zbieranowski, I., Bhattacharya, N., Catzavelos, G. C., Klotz, L. H. and Slingerland, J. M.: Loss of cyclin-dependent kinase inhibitor p27Kip1 is a novel prognostic factor in localized human prostate adenocarcinoma. Cancer Res., 58: 542, 1998.
127. Isaacs, J. T.: Etiology of benign prostatic hyperplasia. Eur. Urol., 25: 6, 1994.
128. Casalone, R., Portentoso, P., Granata, P., Minelli, E., Righi, R., Meroni, E., Pozzi, E. and Chiaravalli, A. M.: Chromosome changes in benign prostatic hyperplasia and their significance in the origin of prostatic carcinoma. Cancer Genet. Cytogenet., 68: 126, 1993.
129. Aly, M. S., Cin, P. D., Van de Voorde, W., van Poppel, H., Ameye, F., Baert, L. and Van den Berghe, H.: Chromosome abnormalities in benign prostatic hyperplasia. Genes Chromosomes Cancer, 9: 227, 1994.
130. Qian, J., Bostwick, D. G., Takahashi, S., Borell, T. J., Brown, J. A., Lieber, M. M. and Jenkins, R. B.: Comparison of fluorescence in situ hybridization analysis of isolated nuclei and routine histological sections from paraffin-embedded prostatic adenocarcinoma specimens. Amer. J. Path., 149: 1193, 1996.
131. Konishi, N., Hiasa, Y., Matsuda, H., Nakamura, M. and Kitahori, Y.: Genetic variations in human benign prostatic hyperplasia detected by restriction landmark genomic scanning. J. Urol., 157: 1499, 1997.
132. Cunha, G. R.: Role of mesenchymal-epithelial interactions in normal and abnormal development of the mammary gland and prostate. Cancer, 74: 1030, 1994.
133. McNeal, J. E.: Origin and evolution of benign prostatic enlargement. Invest. Urol., 15: 340, 1978.
134. Bierhoff, E., Walljasper, U., Hofmann, D., Vogel, J., Wernert, N. and Pfeifer, U.: Morphological analogies of fetal prostate stroma and stromal nodules in BPH. Prostate, 31: 234, 1997.
135. Claus, S., Wrenger, M., Senge, T. and Schulze, H.: Immunohistochemical determination of age related proliferation rates in normal and benign hyperplastic human prostates. Urol. Res., 21: 305, 1993.
136. Cardillo, M., Berchem, G., Tarkington, M. A., Krajewski, S., Krajewski, M., Reed, J. C., Tehan, T., Ortega, L., Lage, J. and Gelmann, E. P.: Resistance to apoptosis and up regulation of Bcl-2 in benign prostatic hyperplasia after androgen deprivation. J. Urol., 158: 212, 1997.
137. Claus, S., Berges, R., Senge, T. and Schulze, H.: Cell kinetic in epithelium and stroma of benign prostatic hyperplasia. J. Urol., 158: 217, 1997.
138. Grignon, D. J. and Sakr, W. A.: Atypical adenomatous hyperplasia of the prostate: a critical review. Eur. Urol., 30: 206, 1996.
139. Epner, D. E. and Coffey, D. S.: There are multiple forms of glyceraldehyde-3-phosphate dehydrogenase in prostate cancer cells and normal prostate tissue. Prostate, 28: 372, 1996.
140. Sirover, M. A.: Role of the glycolytic protein, glyceraldehyde-3-phosphate dehydrogenase, in normal cell function and in cell pathology. J. Cell Biochem., 66: 133, 1997.
141. Bonkhoff, H.: Role of the basal cells in premalignant changes of the human prostate: a stem cell concept for the development of prostate cancer. Eur. Urol., 30: 201, 1996.
142. Byrne, R. L., Horne, C. H., Robinson, M. C., Autzen, P., Apakama, I., Bishop, R. I., Neal, D. E. and Hamdy, F. C.: The expression of waf-1, p53 and bcl-2 in prostatic adenocarcinoma. Brit. J. Urol., 79: 190, 1997.
143. Krajewska, M., Krajewski, S., Epstein, J. I., Shabaik, A., Sauvageot, J., Song, K., Kitada, S. and Reed, J. C.: Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers. Amer. J. Path., 148: 1567, 1996.
144. Fraga, C. F., True, L. D. and Kirk, D.: Enhanced expression of the mesenchymal marker, vimentin, in hyperplastic versus normal human prostatic epithelium. J. Urol., 159: 270, 1998.
145. Partin, A. W., Getzenberg, R. H., CarMichael, M. J., Vindivich, D., Yoo, J., Epstein, J. I. and Coffey, D. S.: Nuclear matrix protein patterns in human benign prostatic hyperplasia and prostate cancer. Cancer Res., 53: 744, 1993.
146. Cote, R. J., Shi, Y., Groshen, S., Feng, A. C., Cordon-Cardo, C., Skinner, D. and Lieskovosky, G.: Association of p27Kip1 levels with recurrence and survival in patients with stage C prostate carcinoma. J. Natl. Cancer Inst., 90: 916, 1998.
147. Cheville, J. C., Lloyd, R. V., Sebo, T. J., Cheng, L., Erickson, L., Bostwick, D. G., Lohse, C. M. and Wollan, P.: Expression of p27Kip1 in prostatic adenocarcinoma. Mod. Path., 11: 324, 1998.
148. Cordon-Cardo, C., Koff, A., Drobnjak, M., Capodieci, P., Osman, I., Millard, S. S., Gaudin, P. B., Fazzari, M., Zhang, Z. F., Massague, J. and Scher, H. I.: Distinct altered patterns of p27Kip1 gene expression in benign prostatic hyperplasia and prostatic carcinoma. J. Natl. Cancer Inst., 90: 128, 1998.